Ifrah Law represents major health, pharmaceutical and biotechnology companies and executives in the defense of federal and state criminal prosecutions and in civil litigation. In fact, our founding partner has been listed by Nightingale’s Healthcare News as one of 12 outstanding fraud and compliance attorneys in the U.S. and recognized by LexisNexis as an expert in healthcare and securities fraud.
We have represented some of the largest players in the healthcare and pharmaceutical industry, including pharmaceutical giant Merck & Co. In one such case, we obtained a dismissal of a complaint alleging million dollar claims under the False Claims Act. We have also successfully represented the owner of a pharmaceutical supply company who was indicted for multiple counts of false statements relating to commercial transactions in the secondary wholesale market. Through our persistence and responsiveness, we prevailed in convincing the U.S. Attorney handling the case to dismiss the indictment in its entirety.
Ifrah Law successfully defended a government contractor against claims by a terminated company employee. Our client, a health care professional supplier, faced allegations that it failed to offer the former employee COBRA insurance coverage, as required under the COBRA statute.
Ifrah Law conducted a bench trial in the U.S. District Court for the Eastern District of Virginia in January 2012. The judge sustained minimal claims and awarded the plaintiff a mere $500.
(Middlebrooks v. Godwin Corporation, U.S. District Court, Eastern District of Virginia, No. 1:10CV1306))
Jeff Ifrah successfully represented global healthcare leader Merck in a False Claims Act qui tam suit and got the case dismissed.
The suit involved a whistleblower that worked for a healthcare buying company (a group purchasing organization that purchases supplies and drugs). Terminated from the buying group, the employee alleged she was retaliated against because of issues she raised about the buying process.
The case was brought before the U.S. District Court for the Northern District of Texas, and 18 drug companies were named as defendants in an alleged bribery scheme. Jeff represented Merck, which was one of the named defendants. He filed a successful motion to dismiss the complaint, based on the former employee’s alarming lack of specificity in her claim.
Not only was our motion to dismiss successful, it was efficient: Jeff won the dismissal roughly one year after Merck and the other defendants were originally served.
(United States ex rel. Fitzgerald v. Novation LLC, et al., S.D. Tex., No. 3:03-CV-01589))